{"altmetric_id":2743086,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["Anti_CancerDrug"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa60b3cf058f610006a63","doi":"10.1097\/cad.0000000000000176","first_seen_on":"2014-10-05T07:44:53+00:00","issns":["0959-4973"],"journal":"Anti-Cancer Drugs","last_mentioned_on":1412495071,"links":["http:\/\/journals.lww.com\/anti-cancerdrugs\/Abstract\/publishahead\/Pharmacokinetics_of_low_molecular_weight_heparin.99265.aspx"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/anti-cancerdrugs\/9000\/00000\/Pharmacokinetics_of_low_molecular_weight_heparin.99265.pdf","pubdate":"2014-10-01T00:00:00+00:00","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Pharmacology, Toxicology and Pharmaceutics","Biochemistry, Genetics and Molecular Biology"],"subjects":["antineoplasticagents"],"title":"Pharmacokinetics of low molecular weight heparin in patients with malignant tumors.","type":"article","volume":"Publish Ahead of Print","mendeley_url":"http:\/\/www.mendeley.com\/research\/pharmacokinetics-low-molecular-weight-heparin-patients-malignant-tumors"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4507652,"mean":5.1453542744813,"rank":3052735,"this_scored_higher_than_pct":20,"this_scored_higher_than":935613,"rank_type":"exact","sample_size":4507652,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":120096,"mean":8.2373748948751,"rank":76344,"this_scored_higher_than_pct":25,"this_scored_higher_than":31161,"rank_type":"exact","sample_size":120096,"percentile":25},"this_journal":{"total_number_of_other_articles":632,"mean":1.0824374009509,"rank":222,"this_scored_higher_than_pct":10,"this_scored_higher_than":65,"rank_type":"exact","sample_size":632,"percentile":10},"similar_age_this_journal_3m":{"total_number_of_other_articles":21,"mean":0.94,"rank":10,"this_scored_higher_than_pct":9,"this_scored_higher_than":2,"rank_type":"exact","sample_size":21,"percentile":9}}},"demographics":{"poster_types":{"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1},"by_discipline":{"Medicine and Dentistry":1}}},"geo":{"mendeley":{"CL":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/Anti_CancerDrug\/status\/518668039827374080","license":"datasift","citation_ids":[2743086],"posted_on":"2014-10-05T07:44:31+00:00","author":{"name":"Anti-Cancer Drugs","url":"http:\/\/www.anti-cancerdrugs.com","image":"https:\/\/pbs.twimg.com\/profile_images\/2463122023\/ldiplkizzx7zbw0t3464_normal.jpeg","description":"An internationally refereed journal devoted to the fast publication of innovative investigations into therapeutic agents against cancer","id_on_source":"Anti_CancerDrug","tweeter_id":"734874170","geo":{"lt":null,"ln":null},"followers":56},"tweet_id":"518668039827374080"}]}}